Incremental Value of Magnetic Resonance Imaging in Selection of Pancreatic Cancer Patients for Surgery (MAGIPAC): A Randomized Clinical Trial.
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Pancreatic Cancer
- Sponsor
- University of Aarhus
- Enrollment
- 200
- Locations
- 3
- Primary Endpoint
- Change in treatment strategy
- Status
- Recruiting
- Last Updated
- 5 months ago
Overview
Brief Summary
The aim of the study is to examine the incremental value of using magnetic resonance imaging (MRI) in addition to computed tomography (CT) in the diagnostic workup of pancreatic cancer patients.
Detailed Description
The aim of the study is to examine the incremental value of using magnetic resonance imaging (MRI) in addition to computed tomography (CT) in the diagnostic workup of pancreatic cancer patients. We will conduct a nationwide, prospective clinical trial to examine the incremental value of using MRI for identification of liver metastases in pancreatic cancer patients.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- Not provided
Outcomes
Primary Outcomes
Change in treatment strategy
Time Frame: 1 week
Change in treatment strategy from intended curative resection to other treatment based on MRI scan
Secondary Outcomes
- Surgery(1 month)
- Intraoperatively detected liver metastases(1 month)
- Liver metastases(1 week)
- Overall survival (1-year)(1 year)
- Resection(1 month)
- Overall survival (3-year)(3 years)
- Recurrence-free survival(3 years)
- Healthcare costs(3 years)